InvestorsHub Logo
Followers 0
Posts 1103
Boards Moderated 0
Alias Born 05/12/2011

Re: synaesthesia post# 33570

Wednesday, 06/08/2011 2:40:18 AM

Wednesday, June 08, 2011 2:40:18 AM

Post# of 92697
The more positive aspect to focus on, in regards to the smoker's option being sold in europe, is the fact that SFIO demonstrates they have the ability to get their product into an open market. But are they wasting any money marketing smoker's option in europe? No. Because SFIO's goal is to market RE/AL first in the US, and then expand RE/AL globally. RE/AL is the focus here, and it's about to explode. I hope you understand that. Now, considering SFIO isn't advertising smoker's option in europe, I think it's naive for you to assume they're generating much profit. They're probably doing okay, sure. Which is a good sign, considering they pay little to no attention to smoker's option, and spend 99% of their work on getting RE/AL into the United States' open market. It wouldn't help SFIO to make public average revenue numbers from smoker's option when they've made it clear in the PRs that our focus as investors, needs to be on RE/AL and what's going on with RE/AL. We're right at the brink of what we've been waiting for. It's finally happening

Put yourself in their position. Would you really release those numbers? I know I would not. No way would I do that.